Fig. 4
From: A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Neutralizing titers of 32 human sera CNE2-EBV-GFP virus infection of B cells determined by FCM and HCIS. A Neutralizing titers of 32 human sera determined by FCM. Data are shown as mean ± SEM (n = 2). Curves were fit using four parameters nonlinear regression. B Neutralizing titers of 32 human sera determined by HCIS. Data are shown as mean ± SEM (n = 2). Curves were fit using four parameters nonlinear regression. C Half maximal neutralizing dilution fold (ND50) of 32 human sera determined by FCM and HCIS. Horizontal lines represent mean ± SEM. D Correlation of half maximal neutralizing dilution fold (ND50) obtained by FCM and HCIS